MedTrace Logo

Effectiveness of CAT-GSH for Returning Patients

NCT06806176 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-10-03

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if cognitive analytic therapy-guided self-help (CAT-GSH) is comparable to cognitive behavioural therapy-guided self-help (CBT-GSH) in terms of whether it is effective and acceptable for people with anxiety or low mood, who are returning to NHS Talking Therapy services for further treatment. The main questions it aims to answer are:

* Does CAT-GSH work well and feel acceptable for people coming back to the Talking Therapies service, compared to CBT-GSH, when taking their characteristics (like age) into account
* Does CAT-GSH work well and feel acceptable for people coming back to the Talking Therapies service, compared to those using CBT-GSH for the first time, when taking their characteristics (like age) into account?

Participants will:

* Choose their preferred treatment
* Complete 6 sessions of either CAT-GSH or CBT-GSH
* Sessions will be weekly or bi-weekly
* Complete routine outcome measures before, during and at the end of therapy

Conditions

Interventions

BEHAVIORAL

Cognitive analytic therapy guided self-help (CAT-GSH)

Six session CAT-GSH treatment

BEHAVIORAL

Cognitive behavioural therapy guided self-help (CBT-GSH)

Six session CBT-GSH treatment

Sponsors & Collaborators

  • Catalyse CAT Limited

    collaborator UNKNOWN

  • Tameside and Glossop Talking Therapies service

    collaborator UNKNOWN

  • Leeds Mental Wellbeing service

    collaborator UNKNOWN

  • University of Sheffield

    lead OTHER

Principal Investigators

  • Andrew J Laphan · University of Sheffield

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-30
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06806176 on ClinicalTrials.gov